MEDICA and COMPAMED 2022 Planning Enters Next Stage, Exhibitors Can Still Register
By LabMedica International staff writers Posted on 21 Jul 2022 |

The planning for the world’s leading medical trade fair MEDICA 2022 as well as for COMPAMED 2022, the No. 1 trade fair for suppliers of the medical technology industry, organized by Messe Düsseldorf (Düsseldorf, Germany), has entered the next stage. The current number of exhibitor registrations indicates that participation will surpass last year’s results (MEDICA 2021: 3,033; COMPAMED 2021: 490). Exhibitors can still register online for all segments at MEDICA and COMPAMED which will take place concurrently from November 14 – 17, 2022 at the fairgrounds in Düsseldorf, Germany.
In their globally unique combination, MEDICA 2022 and COMPAMED 2022 will again reflect the entire medical technology value and process chains and present a comprehensive range of medical products, devices and instruments. In 2021, 46,000 trade visitors took part in both events (73% international participation). The focus segments of the MEDICA trade fair are: Laboratory Technology and Diagnostics, Medical Technology and Electromedicine (Imaging and Diagnostics/ Medical Equipment and Devices), Consumer Goods and Consumables, Physiotherapy and Orthopedic Technology, and IT Systems and IT Solutions.
For years, startups from all countries have always participated in MEDICA and COMPAMED in large numbers, both with their own stands and as part of joint stands. The MEDICA START-UP PARK offers an attractive opportunity for participation, especially for first-time exhibitors. In addition to booth presentations, start-ups and scale-ups (companies in the next stage of development) will again provide interesting insights into their current projects in various pitch and presentation formats. For example, the MEDICA DISRUPT sessions, the 11th MEDICA START-UP COMPETITION and the 14th Healthcare Innovation World Cup will all be program highlights at the MEDICA CONNECTED HEALTHCARE FORUM. Overall, about 120 speakers and more than 100 startups will be on hand to discuss digital innovations for mobile and connected healthcare of the future.
Further forums integrated into the individual thematic segments of the trade fair provide a connection to the product innovations and best practices of their application in everyday medical practice. In addition to the MEDICA CONNECTED HEALTHCARE FORUM, these include the MEDICA HEALTH IT FORUM, the MEDICA TECH FORUM, the MEDICA LABMED FORUM and the MEDICA ECON FORUM. The MEDICA conference program also provides a content link to the trend topics of the market and the trade fair. An example is the 45th German Hospital Day, a leading event for the top management of German hospitals, which this year will be held face-to-face again. Two other (English language) conferences will address a mainly international audience: the Conference on Disaster and Military Medicine DiMiMED, and the MEDICA MEDICINE + SPORTS CONFERENCE for the international professional sports medicine and sports science sector.
In order to keep up to date with trends in the preliminary development or manufacturing stages of the medical technology industry, COMPAMED is and remains the must-attend event. This is where supplier companies present a wealth of high-tech and service solutions. Components, microsystems technology, materials processing and coatings, additive manufacturing/ 3D printing, manufacturing technology and machines, packaging and services are key segments that are also reflected by the programs of the two integrated specialist forums: The COMPAMED HIGH-TECH FORUM organized by the IVAM Microtechnology Association and the COMPAMED SUPPLIERS FORUM managed by the trade publication Devicemed. Demand for micro components and processes in the context of digitization and patient-centered diagnostics remains strong since they key to ultra-precise manufacturing and the foundation for lightweight, portable and interconnected devices.
“The medical technology industry right now needs MEDICA and COMPAMED as strong platforms for international exchange, cooperation and business. Because the market is in flux. In certain areas, the pandemic is causing increased demand, for example in point-of-care diagnostics. In addition, companies are seeing an increasing necessity to work jointly with their supply and manufacturing partners to ensure delivery capacity during a time of sharply rising prices and scarce components,” said Christian Grosser, Director Health & Medical Technologies at Messe Düsseldorf. “International networking also helps to open up new markets. You can broaden the base for your own business, while alleviating the effects of obstacles, uncertainties or even sanctions that may apply to certain national markets.”
Related Links:
Messe Düsseldorf
Latest Industry News
- ECCMID Congress Name Changes to ESCMID Global
- Bosch and Randox Partner to Make Strategic Investment in Vivalytic Analysis Platform
- Siemens to Close Fast Track Diagnostics Business
- Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics
- Sysmex and Hitachi Collaborate on Development of New Genetic Testing Systems
- Sysmex and CellaVision Expand Collaboration to Advance Hematology Solutions
- BD and Techcyte Collaborate on AI-Based Digital Cervical Cytology System for Pap Testing
- Medlab Middle East 2024 to Address Transformative Potential of Artificial Intelligence
- Seegene and Microsoft Collaborate to Realize a World Free from All Diseases and Future Pandemics
- Medlab Middle East 2024 to Highlight Importance of Sustainability in Laboratories
- Fujirebio and Agappe Collaborate on CLIA-Based Immunoassay
- Medlab Middle East 2024 to Highlight Groundbreaking NextGen Medicine
- bioMérieux Acquires Software Company LUMED to Support Fight against Antimicrobial Resistance
- Roche Acquires LumiraDx's Point of Care Technology for USD 295 Million
- Bruker Acquires IVD Manufacturer ELITech Group and Cell Imaging Company Phasefocus
- AMP Publishes Best Practice Guidance for Slice Testing Approach in Diagnostics
Channels
Clinical Chemistry
view channel
3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models
Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more.jpg)
POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection
Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more
Highly Reliable Cell-Based Assay Enables Accurate Diagnosis of Endocrine Diseases
The conventional methods for measuring free cortisol, the body's stress hormone, from blood or saliva are quite demanding and require sample processing. The most common method, therefore, involves collecting... Read moreMolecular Diagnostics
view channel
Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset
Autoimmune diseases such as multiple sclerosis (MS) are thought to occur partly due to unusual immune responses to common infections. Early MS symptoms, including dizziness, spasms, and fatigue, often... Read more
Blood Test Could Detect HPV-Associated Cancers 10 Years before Clinical Diagnosis
Human papilloma virus (HPV) is known to cause various cancers, including those of the genitals, anus, mouth, throat, and cervix. HPV-associated oropharyngeal cancer (HPV+OPSCC) is the most common HPV-associated... Read moreHematology
view channel
Next Generation Instrument Screens for Hemoglobin Disorders in Newborns
Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more
First 4-in-1 Nucleic Acid Test for Arbovirus Screening to Reduce Risk of Transfusion-Transmitted Infections
Arboviruses represent an emerging global health threat, exacerbated by climate change and increased international travel that is facilitating their spread across new regions. Chikungunya, dengue, West... Read more
POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy
Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more
First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy
Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read moreImmunology
view channel
Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies
Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more
AI Tool Precisely Matches Cancer Drugs to Patients Using Information from Each Tumor Cell
Current strategies for matching cancer patients with specific treatments often depend on bulk sequencing of tumor DNA and RNA, which provides an average profile from all cells within a tumor sample.... Read more
Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment
Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read moreMicrobiology
view channel
Mouth Bacteria Test Could Predict Colon Cancer Progression
Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more.jpg)
Unique Metabolic Signature Could Enable Sepsis Diagnosis within One Hour of Blood Collection
Sepsis is a life-threatening condition triggered by an extreme response of the body to an infection. It requires immediate medical intervention to prevent potential death or lasting damage.... Read morePathology
view channel
Spatial Tissue Analysis Identifies Patterns Associated With Ovarian Cancer Relapse
High-grade serous ovarian carcinoma is the most lethal type of ovarian cancer, and it poses significant detection challenges. Typically, patients initially respond to surgery and chemotherapy, but the... Read more.jpg)
Unique Hand-Warming Technology Supports High-Quality Fingertip Blood Sample Collection
Warming the hand is an effective way to facilitate blood collection from a fingertip, yet off-the-shelf solutions often do not fulfill laboratory requirements. Now, a unique hand-warming technology has... Read moreTechnology
view channel
New Diagnostic System Achieves PCR Testing Accuracy
While PCR tests are the gold standard of accuracy for virology testing, they come with limitations such as complexity, the need for skilled lab operators, and longer result times. They also require complex... Read more
DNA Biosensor Enables Early Diagnosis of Cervical Cancer
Molybdenum disulfide (MoS2), recognized for its potential to form two-dimensional nanosheets like graphene, is a material that's increasingly catching the eye of the scientific community.... Read more
Self-Heating Microfluidic Devices Can Detect Diseases in Tiny Blood or Fluid Samples
Microfluidics, which are miniature devices that control the flow of liquids and facilitate chemical reactions, play a key role in disease detection from small samples of blood or other fluids.... Read more